Clin2
NCT06759298Possibly a fitNot yet recruiting

Methylphenidate for borderline personality disorder symptoms

Borderline Personality Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests whether the medication methylphenidate (brand name Concerta) can help reduce symptoms like impulsivity and mood swings in people with borderline personality disorder. Methylphenidate is typically used for ADHD but may affect brain chemicals related to impulse control.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
60 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You must be between 18 and 50 years old.
  • You must have a formal diagnosis of borderline personality disorder, confirmed by a clinical interview.
  • You must have at least moderate levels of impulsivity and mood swings.
  • You cannot be taking stimulant medications or other drugs that conflict with methylphenidate (Concerta).
  • You cannot have ADHD or other conditions where Concerta is usually prescribed, nor severe mental health issues like schizophrenia or bipolar disorder.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06683014Recruiting· Phase 2
MDMA study for borderline personality disorder

This trial tests if a single dose of MDMA, given under supervision, can help people with borderline personality disorder (BPD). You will stay overnight after the session and be followed up for two weeks.

New Haven, Connecticut
NCT02097706Recruiting· Phase 2
Drug study for borderline personality disorder

This Phase 2 study tests a new medicine for people with borderline personality disorder (BPD) to see if it can improve symptoms. You may qualify if you have a confirmed BPD diagnosis and meet safety and medication rules.

Melbourne, Victoria
NCT05942651Recruiting
tMS for impulsivity in borderline personality disorder

This trial studies whether magnetic brain stimulation (tMS) can reduce impulsive symptoms in people with borderline personality disorder. It may help by changing how brain networks involved in impulse control work.

Bron, AURA
NCT06493708Recruiting
EMDR Therapy for Borderline Personality Disorder

This study tests whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can help people with Borderline Personality Disorder (BPD). EMDR is a type of talk therapy often used for trauma, and this trial wants to see if it can improve BPD symptoms.

Brescia, Brescia
NCT05246527Recruiting
Exercise study to see effects in borderline personality disorder

This study looks at how a physical exercise session affects thinking and other outcomes in people diagnosed with borderline personality disorder. It may help researchers understand whether exercise has short-term benefits or risks for this group.

Bonn, North Rhine-Westphalia
NCT07197502Recruiting
Treating borderline personality disorder with brain stimulation

This study tests if a non-invasive brain stimulation technique called rTMS can help treat borderline personality disorder (BPD). It aims to see if this treatment can improve symptoms and is safe for people with BPD.

Los Angeles, California

Hear when a new Borderline Personality Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.